Targeting PD-L1 in solid cancer with myeloid cells expressing a CAR-like immune receptor
K. M. Chen, D. Grun, B. Gautier, S. Venkatesha, M. Maddox, A.-H. Zhang, P. Andersen
This study demonstrates that engineered myeloid cells expressing a PD-1-based CAR-like receptor can recognize and attack PD-L1+ solid tumors, enhancing phagocytosis and slowing tumor growth in vivo.
bioRxiv · Jan 29, 2024 · PreprintImmunology